Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Pemtumomab

Catalog #:   DHD14209 Specific References (27) DATASHEET
Host species: Mouse
Isotype: IgG1, kappa
Applications: Research Grade Biosimilar
Expression system: Mammalian Cells
Overview

Catalog No.

DHD14209

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Mouse

Isotype

IgG1, kappa

Clonality

Monoclonal

Target

PEMT, CA 15-3, H23AG, Peanut-reactive urinary mucin, PEM, EMA, Cancer antigen 15-3, MUC-1, Episialin, MUC1-CT, MUC1-beta, Tumor-associated mucin, CD227, Polymorphic epithelial mucin, KL-6, MUC1-alpha, MUC1, PUM, Krebs von den Lungen-6, MUC1-NT, Tumor-associated epithelial membrane antigen, Mucin-1, Breast carcinoma-associated antigen DF3, Carcinoma-associated mucin

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P15941

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Pemtumomab

Clone ID

Pemtumomab

Data Image
References

Staining of MUC1 in ovarian cancer tissues with PankoMab-GEX detecting the tumour-associated epitope, TA-MUC1, as compared to antibodies HMFG-1 and 115D8., PMID:23275306

MUC1 immunotherapy., PMID:20635898

Xanthogranulomatous reaction to a ruptured galactocele., PMID:20202042

Human anti-mouse IgM and IgG responses in ovarian cancer patients after radioimmunotherapy with 90Y-muHMFG1., PMID:19035301

Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)., PMID:18684557

Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer., PMID:18661524

MUC-1 mucin in normal human salivary glands detected by HMFG-1 and HMFG-2 monoclonal antibodies., PMID:18321359

The MUC1 HMFG1 glycoform is a precursor to the 214D4 glycoform in the human uterine epithelial cell line, HES., PMID:17989354

Development of ELISAs for quantification of HMFG1-specific human anti-mouse IgG and IgM antibodies., PMID:17922458

Extraperitoneal leakage as a possible explanation for failure of one-time intraperitoneal treatment in ovarian cancer., PMID:17803445

High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC)., PMID:17692456

Decreased intraperitoneal disease recurrence in epithelial ovarian cancer patients receiving intraperitoneal consolidation treatment with yttrium-90-labeled murine HMFG1 without improvement in overall survival., PMID:17354223

Monoclonal and bispecific antibodies as novel therapeutics., PMID:16648969

Phase III trial of intraperitoneal therapy with yttrium-90-labeled HMFG1 murine monoclonal antibody in patients with epithelial ovarian cancer after a surgically defined complete remission., PMID:16446329

Consolidation for ovarian cancer in remission., PMID:16446325

Concurrent radiotherapy and tumor targeting with 111In-HMFG1-F(ab')2 in patients with MUC1-positive non-small cell lung cancer., PMID:16334158

Characterisation and internalisation of recombinant humanised HMFG-1 antibodies against MUC1., PMID:16265351

[Immunotherapy--perspectives in therapy of ovarian carcinomas]., PMID:15587893

Gastric metaplasia and small bowel ulcerogenesis in a case of ulcerative jejunitis not related to celiac disease., PMID:15494871

Reversal of glandular polarity in the lymphovascular compartment of breast cancer., PMID:15452174

Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme., PMID:15150594

A phase I trial of idiotypic vaccination with HMFG1 in ovarian cancer., PMID:15127236

Intraperitoneal radioimmunotherapy in an ovarian carcinoma mouse model: Effect of the radionuclide., PMID:14675343

Technology evaluation: R-1549, Antisoma/Roche., PMID:14601527

Biologic and immunologic therapies for ovarian cancer., PMID:12743131

SMART? Time will tell., PMID:12442760

Application of extracorporeal immunoadsorption to reduce circulating blood radioactivity after intraperitoneal administration of indium-111-HMFG1-biotin., PMID:11877758

Datasheet

Document Download

Research Grade Pemtumomab.pdf

 

$ 372
Product specifications
100 μg 372 1 mg 1486

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Pemtumomab [DHD14209]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only